Use of Cas9 Targeting and Red Recombination for Designer Phage Engineering
Journal of Microbiology · 2024-01 · 62 (1) · 1-10
DOI: 10.1007/s12275-024-00107-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Microbiology, online erschienen am 01.02.2024. Verfasst von Shin-Yae Choi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Program of Biopharmaceutical Science and Department of Pharmacy, College of Pharmacy and Institute of Pharmaceutical Sciences, CHA University, Gyeong…. Hauptthemen laut MEDLINE: Bacteriophages. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 37 Literaturangaben.
Abstract (Originalsprache)
Bacteriophages (phages) are natural antibiotics and biological nanoparticles, whose application is significantly boosted by recent advances of synthetic biology tools. Designer phages are synthetic phages created by genome engineering in a way to increase the benefits or decrease the drawbacks of natural phages. Here we report the development of a straightforward genome engineering method to efficiently obtain engineered phages in a model bacterial pathogen, Pseudomonas aeruginosa. This was achieved by eliminating the wild type phages based on the Streptococcus pyogenes Cas9 (SpCas9) and facilitating the recombinant generation based on the Red recombination system of the coliphage λ (λRed). The producer (PD) cells of P. aeruginosa strain PAO1 was created by miniTn7-based chromosomal integration of the genes for SpCas9 and λRed under an inducible promoter. To validate the efficiency of the recombinant generation, we created the fluorescent phages from a temperate phage MP29. A plasmid bearing the single guide RNA (sgRNA) gene for selectively targeting the wild type gp35 gene and the editing template for tagging the Gp35 with superfolder green fluorescent protein (sfGFP) was introduced into the PD cells by electroporation. We found that the targeting efficiency was affected by the position and number of sgRNA. The fluorescent phage particles were efficiently recovered from the culture of the PD cells expressing dual sgRNA molecules. This protocol can be used to create designer phages in P. aeruginosa for both application and research purposes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Program of Biopharmaceutical Science and Department of Pharmacy, College of Pharmacy and Institute of Pharmaceutical Sciences, CHA University, Gyeonggi, 13488, Republic of Korea.
- Program of Biopharmaceutical Science and Department of Pharmacy, College of Pharmacy and Institute of Pharmaceutical Sciences, CHA University, Gyeonggi, 13488, Republic of Korea. youhee@cha.ac.kr.
Zitieren
APA
Choi, S. Y., Romero-Calle, D. X., Cho, H. G., Bae, H. W., & Cho, Y. H. (2024). Use of Cas9 Targeting and Red Recombination for Designer Phage Engineering. Journal of Microbiology, 62(1), 1-10. https://doi.org/10.1007/s12275-024-00107-2
Vancouver
Choi SY, Romero-Calle DX, Cho HG, Bae HW, Cho YH. Use of Cas9 Targeting and Red Recombination for Designer Phage Engineering. Journal of Microbiology. 2024;62(1):1-10. doi:10.1007/s12275-024-00107-2
BibTeX
@article{Choi2024,
author = {Choi, Shin-Yae and Romero-Calle, Danitza Xiomara and Cho, Han-Gyu and Bae, Hee-Won and Cho, You-Hee},
title = {Use of Cas9 Targeting and Red Recombination for Designer Phage Engineering},
journal = {Journal of Microbiology},
year = {2024},
volume = {62},
number = {1},
pages = {1--10},
doi = {10.1007/s12275-024-00107-2}
}
EUVIMED